Trial NCT04675983

View at ClinicalTrials.gov 
Org. Study IDs: CIBI308E302

Last trial update was posted on 2023-03-02

MeSH Interventions

Capecitabine Fluorouracil Oxaliplatin Ramucirumab

MeSH Conditions

Adenocarcinoma

Other Conditions

Gastric Adenocarcinoma

Stopping Reasons

Due to the company's development strategy adjustment, Innovent Biologics has decided not to continue this study after consultation with investigators

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID